Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
ABOUT THIS PAGE
48
PharmaCompass offers a list of Rifamycin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Rifamycin manufacturer or Rifamycin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rifamycin manufacturer or Rifamycin supplier.
A Rifamycin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rifamycin, including repackagers and relabelers. The FDA regulates Rifamycin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rifamycin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rifamycin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Rifamycin supplier is an individual or a company that provides Rifamycin active pharmaceutical ingredient (API) or Rifamycin finished formulations upon request. The Rifamycin suppliers may include Rifamycin API manufacturers, exporters, distributors and traders.
click here to find a list of Rifamycin suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Rifamycin DMF (Drug Master File) is a document detailing the whole manufacturing process of Rifamycin active pharmaceutical ingredient (API) in detail. Different forms of Rifamycin DMFs exist exist since differing nations have different regulations, such as Rifamycin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Rifamycin DMF submitted to regulatory agencies in the US is known as a USDMF. Rifamycin USDMF includes data on Rifamycin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Rifamycin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Rifamycin suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rifamycin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rifamycin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rifamycin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rifamycin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rifamycin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rifamycin suppliers with NDC on PharmaCompass.
Rifamycin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rifamycin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Rifamycin GMP manufacturer or Rifamycin GMP API supplier for your needs.
A Rifamycin CoA (Certificate of Analysis) is a formal document that attests to Rifamycin's compliance with Rifamycin specifications and serves as a tool for batch-level quality control.
Rifamycin CoA mostly includes findings from lab analyses of a specific batch. For each Rifamycin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rifamycin may be tested according to a variety of international standards, such as European Pharmacopoeia (Rifamycin EP), Rifamycin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rifamycin USP).
